Answer
Simbrinza lowers eye pressure by reducing aqueous humour production: brinzolamide inhibits carbonic anhydrase II, while brimonidine activates alpha-2 adrenergic receptors and inhibits adenylate cyclase; brimonidine also increases uveoscleral fluid outflow.
Sources for this answer
- SIMBRINZA 10 mg/mL + 2 mg/mL eye drops, suspensionNovartis Pharmaceuticals UK Ltd · emc · SmPC §5.1 Pharmacodynamic properties · Version 10Document updated
Sources checked